Loading…

Grant Application Form

Complete all steps to submit your application

Pre-filled from selected grant
CoVPN 3004 - A Phase 3, Randomized, Observer-Blinded, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Immunogenicity of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine Lab

NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · United States · $149.8M USD

Back to Grant
Grant Information

Provide details about the grant you are applying for

$
Applicant Information

Tell us about yourself and your organization

$
Proposal & Supporting Documents

Provide additional details and upload your proposal document

Accepted formats: PDF, DOC, DOCX. Max size: 10MB